Connect with others who understand.

Sign up Log in
Resources
About MyAutismTeam
Powered By

Overview
Cibalith-S is a prescription drug. Its active ingredient, lithium carbonate, was first approved by the Food and Drug Administration (FDA) in 1970. In children with autism spectrum disorders (ASD), Cibalith-S can be effective in addressing mood disorders such as mania and euphoria. Cibalith-S is also known by its drug name, Lithium carbonate.

Cibalith-S is not suitable for children under the age of 12. Cibalith-S is not recommended for use in pregnant women.

Cibalith-S is a mood stabilizer. Cibalith-S is believed to work by changing the balance of neurotransmitters in the brain.

How do I take it?
Before prescribing Cibalith-S, your doctor may take your child’s weight and height. It is recommended to chart the child’s growth every three months while taking Cibalith-S to ensure that the drug is not interfering with physical development.

Cibalith-S is taken orally twice a day.

Always follow your doctor’s instructions exactly when taking Cibalith-S.

Results
A retrospective review published in 2014 charted the experiences of 30 children and adolescents diagnosed with ASD and treated with Lithium carbonate (Cibalith-S). Healthcare providers rated 71 percent of the participants improved in symptoms including mania and euphoria.

Side effects
Cibalith-S may interfere with bone formation in children.

Common side effects of Cibalith-S are vomiting, tremors, fatigue, irritability, and bed-wetting.

Many drugs can cause allergic reactions that, in the most serious cases, can result in death. Seek immediate medical help if you experience signs of a severe allergic reaction such as difficulty breathing or swelling in the face, throat, eyes, lips or tongue.

Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data Policy and Privacy policies.Your privacy is our priority Lock Icon
Already a Member? Log in